Detalhe da pesquisa
1.
Homologous and Heterologous Covid-19 Booster Vaccinations.
N Engl J Med
; 386(11): 1046-1057, 2022 03 17.
Artigo
Inglês
| MEDLINE | ID: mdl-35081293
2.
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
J Infect Dis
; 228(12): 1662-1666, 2023 12 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37561027
3.
The Coronavirus Disease 2019 Pandemic Unmasked the Challenges Faced by Early-Stage Faculty in Infectious Diseases: A Call to Action.
Clin Infect Dis
; 76(4): 753-759, 2023 02 18.
Artigo
Inglês
| MEDLINE | ID: mdl-36131321
4.
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial.
Clin Infect Dis
; 77(4): 560-564, 2023 08 22.
Artigo
Inglês
| MEDLINE | ID: mdl-37036397
5.
Detection and Kinetics of Subgenomic Severe Acute Respiratory Syndrome Coronavirus 2 RNA Viral Load in Longitudinal Diagnostic RNA-Positive Samples.
J Infect Dis
; 226(5): 788-796, 2022 09 13.
Artigo
Inglês
| MEDLINE | ID: mdl-35150571
6.
Self-Assessed Severity as a Determinant of Coronavirus Disease 2019 Symptom Specificity: A Longitudinal Cohort Study.
Clin Infect Dis
; 75(1): e1180-e1183, 2022 08 24.
Artigo
Inglês
| MEDLINE | ID: mdl-35152299
7.
Antibody Titers against Mpox Virus after Vaccination.
N Engl J Med
; 389(24): 2299-2301, 2023 Dec 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38091537
8.
Prevalence of strongyloidiasis among cardiothoracic organ transplant candidates in a non-endemic region: A single-center experience with universal screening.
Transpl Infect Dis
; 23(4): e13614, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-33844416
9.
Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial.
medRxiv
; 2023 Mar 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37034641
10.
Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
medRxiv
; 2023 Jun 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37333252
11.
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants.
NPJ Vaccines
; 8(1): 98, 2023 Jul 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37433788
12.
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial.
Nat Med
; 29(9): 2334-2346, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37640860
13.
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses.
medRxiv
; 2022 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35898343
14.
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant.
Cell Rep Med
; 3(7): 100679, 2022 07 19.
Artigo
Inglês
| MEDLINE | ID: mdl-35798000
15.
Heterologous SARS-CoV-2 Booster Vaccinations - Preliminary Report.
medRxiv
; 2021 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34671773